[1]. I. Kirsch 1997 Specifying nonspecifics: psychological mechanisms of placebo effects A. Harrington The Placebo Effect. An Interdisciplinary Exploration Harvard University Press Cambridge 166–186.

[1]. I. Kirsch 1997 Specifying nonspecifics: psychological mechanisms of placebo effects A. Harrington The Placebo Effect. An Interdisciplinary Exploration Harvard University Press Cambridge 166–186.)| false
• Search Google Scholar
• Export Citation

[2]. Ross, S., Buckalew, L. W.: Placebo agentry: assessment of drug and placebo effects. In: White, L., Tursky, B., Schwartz, G. E. (eds): Placebo — Theory, Research, and Mechanisms. Guilford, New York, 1985, pp. 67–82.

[2]. Ross, S., Buckalew, L. W.: Placebo agentry: assessment of drug and placebo effects. In: White, L., Tursky, B., Schwartz, G. E. (eds): Placebo — Theory, Research, and Mechanisms. Guilford, New York, 1985, pp. 67–82.)| false
• Search Google Scholar
• Export Citation

[3]. A. Leslie 1954 Ethics and practice of placebo therapy Am. J. Med. 16 854–862.

[3]. A. Leslie 1954 Ethics and practice of placebo therapy Am. J. Med. 16 854–862.)| false
• Search Google Scholar
• Export Citation

[4]. D. E. Moerman 2002 Explanatory mechanisms for placebo effects: cultural influences and the meaning response H. A. Guess A. Kleinman J. W. Kusek L. W. Engel The Science of the Placebo. Toward an Interdisciplinary Research Agenda BMJ Books London 77–107.

[4]. D. E. Moerman 2002 Explanatory mechanisms for placebo effects: cultural influences and the meaning response H. A. Guess A. Kleinman J. W. Kusek L. W. Engel The Science of the Placebo. Toward an Interdisciplinary Research Agenda BMJ Books London 77–107.)| false
• Search Google Scholar
• Export Citation

[5]. H. Nash 1962 Psychologic effects of amphetamines and barbiturates J. Nerv. Ment. Dis. 134 203–217.

[5]. H. Nash 1962 Psychologic effects of amphetamines and barbiturates J. Nerv. Ment. Dis. 134 203–217.)| false
• Search Google Scholar
• Export Citation

[6]. M. Z. Hussain 1972 Effect of shape of medication in treatment of anxiety states Br. J. Psychiatry 120 507–509.

[6]. M. Z. Hussain 1972 Effect of shape of medication in treatment of anxiety states Br. J. Psychiatry 120 507–509.)| false
• Search Google Scholar
• Export Citation

[7]. L. W. Buckalew S. Ross 1991 Medication property effects on expectations of action Drug Dev. Res. 23 101–108.

[7]. L. W. Buckalew S. Ross 1991 Medication property effects on expectations of action Drug Dev. Res. 23 101–108.)| false
• Search Google Scholar
• Export Citation

[8]. L. Lasagna 1955 Placebos. Sci. Am. 193 68–71.

[8]. L. Lasagna 1955 Placebos. Sci. Am. 193 68–71.)| false
• Search Google Scholar
• Export Citation

[9]. A. B. Overgaard J. Møllerdash Sonnergaard L. L. Christrup et al.2001 Patients’ evaluation of shape, size and colour of solid dosage forms Pharm. World Sci. 23 185–188.

[9]. A. B. Overgaard J. Møllerdash Sonnergaard L. L. Christrup 2001 Patients’ evaluation of shape, size and colour of solid dosage forms Pharm. World Sci. 23 185–188.)| false
• Search Google Scholar
• Export Citation

[10]. R. E. Sallis L. W. Buckalew 1984 Relation of capsule color and perceived potency Percept. Mot. Skills 58 897–898.

[10]. R. E. Sallis L. W. Buckalew 1984 Relation of capsule color and perceived potency Percept. Mot. Skills 58 897–898.)| false
• Search Google Scholar
• Export Citation

[11]. K. E. Coffield L. W. Buckalew 1988 A study for color preferences of drugs and implications for compliance and drug-taking J. Alcohol Drug Educ. 34 28–36.

[11]. K. E. Coffield L. W. Buckalew 1988 A study for color preferences of drugs and implications for compliance and drug-taking J. Alcohol Drug Educ. 34 28–36.)| false
• Search Google Scholar
• Export Citation

[12]. K. W. Jacobs F. M. Nordan 1979 Classification of placebo drugs: effect of color Percept. Mot. Skills 49 367–372.

[12]. K. W. Jacobs F. M. Nordan 1979 Classification of placebo drugs: effect of color Percept. Mot. Skills 49 367–372.)| false
• Search Google Scholar
• Export Citation

[13]. L. W. Buckalew K. E. Coffield 1982 An investigation of drug expectancy as a function of capsule colour, size, and preparation form J. Clin. Psychopharmacol. 2 245–248.

[13]. L. W. Buckalew K. E. Coffield 1982 An investigation of drug expectancy as a function of capsule colour, size, and preparation form J. Clin. Psychopharmacol. 2 245–248.)| false
• Search Google Scholar
• Export Citation

[14]. L. W. Buckalew K. E. Coffield 1982 Drug expectations associated with perceptual characteristics: ethnic factors Percept. Mot. Skills 55 915–918.

[14]. L. W. Buckalew K. E. Coffield 1982 Drug expectations associated with perceptual characteristics: ethnic factors Percept. Mot. Skills 55 915–918.)| false
• Search Google Scholar
• Export Citation

[15]. F. Köteles Gy. Bárdos 2007 Expectations of drug effects based on colours and sizes of tablets Mentálhig. Pszichoszom. 8 277–290.

[15]. F. Köteles Gy. Bárdos 2007 Expectations of drug effects based on colours and sizes of tablets Mentálhig. Pszichoszom. 8 277–290.)| false
• Search Google Scholar
• Export Citation

[16]. A. J. de Craen P. J. Roos A. Leonard de Vries et al.1996 Effect of colour of drugs: systematic review of perceived effect of drugs and of their effectiveness Br. Med. J. 313 1624–1626.

[16]. A. J. de Craen P. J. Roos A. Leonard de Vries 1996 Effect of colour of drugs: systematic review of perceived effect of drugs and of their effectiveness Br. Med. J. 313 1624–1626.)| false
• Search Google Scholar
• Export Citation

[17]. F. Köteles D. Fodor Cziboly et al.2009 Expectations of drug effects based on colours and sizes — the importance of learning Clin. Exp. Med. J. 3 99–107.

[17]. F. Köteles D. Fodor Cziboly 2009 Expectations of drug effects based on colours and sizes — the importance of learning Clin. Exp. Med. J. 3 99–107.)| false
• Search Google Scholar
• Export Citation

[18]. F. M. Adams C. E. Osgood 1973 A cross-cultural study of the affective meanings of color J. Cross Cult. Psychol. 4 135–156.

[18]. F. M. Adams C. E. Osgood 1973 A cross-cultural study of the affective meanings of color J. Cross Cult. Psychol. 4 135–156.)| false
• Search Google Scholar
• Export Citation

[19]. A. L. Geers K. Kosbab S. G. Helfer et al.2007 Further evidence for individual differences in placebo responding: an interactionist perspective J. Psychosom. Res. 62 563–570.

[19]. A. L. Geers K. Kosbab S. G. Helfer 2007 Further evidence for individual differences in placebo responding: an interactionist perspective J. Psychosom. Res. 62 563–570.)| false
• Search Google Scholar
• Export Citation

[20]. F. Benedetti M. Amanzio S. Vighetti et al.2006 The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect J. Neurosci. 26 12014–12022.

[20]. F. Benedetti M. Amanzio S. Vighetti 2006 The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect J. Neurosci. 26 12014–12022.)| false
• Search Google Scholar
• Export Citation

[21]. L. W. Buckalew 1982 A cognitive dissonance perspective on the patient compliance problem Psychol. Bull. 3 28–33.

[21]. L. W. Buckalew 1982 A cognitive dissonance perspective on the patient compliance problem Psychol. Bull. 3 28–33.)| false
• Search Google Scholar
• Export Citation

[22]. L. W. Buckalew R. E. Sallis 1986 Patient compliance and medication perception J. Clin. Psychol. 42 49–53.

[22]. L. W. Buckalew R. E. Sallis 1986 Patient compliance and medication perception J. Clin. Psychol. 42 49–53.)| false
• Search Google Scholar
• Export Citation